Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
A 29-year-old Cincinnati woman was awakened by her Apple Watch, which alerted her about an elevated heart rate, prompting her to head to a doctor who notified her of a blood clot.
Anheuser-Busch's top marketing executive Marcel Marcondes addressed the ongoing boycott of Bud Light after protests over the company's partnership with trans influencer Dylan Mulvaney.
UPS recently announced it would equip delivery trucks with air conditioning. Dr. Douglas Casa, CEO of Korey Stringer Institute at the University of Connecticut, spoke with Cheddar News on the dangers of heat stroke and how workers can keep themselves safe from extreme weather.
The push for clean energy is igniting an interest in electric vehicles but charging EVs continues to be a concern for consumers looking to save. Brian Moody, executive editor with Autotrader, joined Cheddar News to discuss how people can make home-charging more affordable.
